Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNanoco Regulatory News (NANO)

Share Price Information for Nanoco (NANO)

Share Price is delayed by 15 minutes
Get Live Data
3.20    -0.20 (-5.88%)
Bid:
3.20
Ask:
3.44
Spread: 0.24 (7.50%)
Market Cap: £5.84m
NANO Live PriceLast checked at - London Stock Exchange

Intraday Nanoco Share Chart

RoHS Update

2 Feb 2015 07:00

RNS Number : 6955D
Nanoco Group PLC
02 February 2015
 



For immediate release

2 February 2015

 

 

 

NANOCO GROUP PLC

("Nanoco" or the "Company")

 

RoHS Update

 

Nanoco Group plc (AIM: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, confirms that a proposed exemption to the Restriction of Hazardous Substances Directive (RoHS) for cadmium-containing quantum dots is shortly expected to be reviewed by Members of the European Parliament ("MEPs").

 

The legislative process includes a period of 60 days' scrutiny of the exemption by MEPs, though formal notification is awaited on the timing of the 60-day review. The legislative process includes the right to an immediate appeal should the European Parliament vote to enact the exemption.

 

The proposal being put forward for review is for an exemption that runs until 30 June 2018. A draft document of the proposed exemption is available at this link: http://ec.europa.eu/enterprise/tbt/en/search/?tbtaction=get.project&Country_ID=EU&num=257&dspLang=en&basdatedeb=14/01/2015&basdatefin=16/01/2015&baspays=&baspays2=&basnotifnum=&basnotifnum2=&bastypepays=ANY&baskeywords=&project_type_num=1&project_type_id=1&lang_id=EN

 

The document acknowledges that it would be "desirable to substitute cadmium in quantum dots" but states that cadmium-free quantum dots "are still in the scientific research stage and years away from production". This is clearly not the case as commercial quantities of cadmium-free quantum dots are currently available from Nanoco, and The Dow Chemical Company's ("Dow") mass production facility in South Korea remains on track for commercial production of cadmium-free quantum dots in the first half of this year.

 

 

Michael Edelman, Nanoco's Chief Executive Officer, said: "We await the decision of the European Parliament but in our view an exemption is entirely inappropriate and in conflict with the RoHS's stated objective of restricting the use of hazardous substances. Nanoco's cadmium-free quantum dots are already available commercially from the Company's Runcorn production facility, and Dow's mass production facility is under construction in South Korea to provide the capability to supply millions of LCD displays. Leading LCD display makers are choosing cadmium-free quantum dots because they are the preferred choice for human and environmental health."

 

For further information, please contact:

 

Nanoco

Tel: +44 (0) 161 603 7900

Michael Edelman, Chief Executive Officer

Mark Sullivan, Interim Chief Financial Officer

Canaccord Genuity - Nomad and Joint Broker

Tel: +44 (0) 20 7523 8000

Simon Bridges

Cameron Duncan

Liberum - Joint Broker

Tel: +44 (0) 20 3100 2000

Simon Atkinson

Richard Bootle

Buchanan

Tel: +44 (0) 20 7466 5000

Mark Court / Sophie Cowles / Stephanie Watson

 

 

 

Notes for editors:

 

About Nanoco Group plc

Nanoco is a world leader in the development and production of cadmium-free quantum dots and other nanomaterials for use in multiple applications including LCD displays, lighting, solar cells and bio-imaging. In the display market, it has an exclusive manufacturing and marketing licensing agreement with The Dow Chemical Company.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based in Concord, MA. Nanoco also has business development executives in Japan, Korea and Taiwan. Its technology is protected worldwide by a large and growing patent estate.

 

Nanoco began trading on the AIM market of the London Stock Exchange in May 2009 under the ticker symbol NANO. For further information please visit: www.nanocogroup.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFMGGZLMMGKZM
Date   Source Headline
22nd Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
18th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
17th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
14th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
10th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
9th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
4th Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
3rd Oct 20247:00 amRNSConclusions of Strategic Review
1st Oct 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
25th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Sep 202410:51 amRNSHolding(s) in Company
24th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
20th Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
12th Sep 20241:08 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSHolding(s) in Company
2nd Sep 20241:34 pmRNSHolding(s) in Company
2nd Sep 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Aug 20247:00 amRNSCommercial Update
29th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
28th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
27th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
23rd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
21st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
16th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
13th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
8th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
7th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
6th Aug 20247:21 amRNSTransaction in Own Shares and Total Voting Rights
5th Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
2nd Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
1st Aug 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
31st Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
30th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
29th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
26th Jul 20249:16 amRNSTransaction in Own Shares and Total Voting Rights
25th Jul 20247:00 amRNSBoard and Management Change
25th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
24th Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
22nd Jul 20247:00 amRNSTransaction in Own Shares and Total Voting Rights
19th Jul 20242:14 pmRNSTransaction in Own Shares and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.